Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-745bb68f8f-f46jp Total loading time: 0 Render date: 2025-02-09T11:58:09.755Z Has data issue: false hasContentIssue false

21 - Treatment of sedative-hypnotic dependence

from Part III - Specific treatments

Published online by Cambridge University Press:  12 May 2010

By
Karim Dar  and
Manoj Kumar
Edited by
Peter Tyrer  and
Kenneth R. Silk
Karim Dar
Affiliation:
Gatehouse Alcohol Clinic St. Bernard's Hospital Southall Middx UK
Manoj Kumar
Affiliation:
Gatehouse Alcohol Clinic St. Bernard's Hospital Southall Middx UK
Peter Tyrer
Affiliation:
Imperial College of Science, Technology and Medicine, London
Kenneth R. Silk
Affiliation:
University of Michigan, Ann Arbor
Get access

Summary

Editor's note

Misuse and dependence upon benzodiazepines, despite much greater awareness of the dangers of these drugs, still appear to be growing problems. Misuse occurs because of dependency upon these drugs that have been prescribed for extended periods with some increasing tolerance on the part of the patient. Misuse also occurs by people who purchase or obtain these drugs by means other than prescription. The growing emphasis on insomnia and the increasing competition among various drug companies to capture the prescription sleeping pill market appears to exacerbate this problem. At the moment, a gradual tapering of the prescribed or illegally used drug, especially by substituting a longer-acting drug for a shorter-acting drug, appears to have the most supporting evidence. Little research has been done on hypnotics compared with the benzodiazepines, and this is a bit of a puzzle.

Introduction

Sedative hypnotic drugs are central nervous system depressants traditionally used to reduce anxiety and induce sleep. The sedatives under consideration in this chapter are benzodiazepines, the Z-drugs (zopiclone, zolpidem and zaleplon) and barbiturates. After their introduction in 1903, barbiturates were supplanted by the benzodiazepines which were introduced in the early 1960s. This was primarily due to concerns about the obvious toxicity of barbiturates, particularly in overdose, and knowledge of their propensity for dependence. After reaching a peak in the early 1980s, prescriptions for benzodiazepines in the UK have shown a substantial reduction; however, while annual prescriptions for benzodiazepines in England fell from 10 million to around 6 million between 1993–2003, those for the Z-drugs rose from 0.3 million to over 4 million over the same time period, mainly in older people (DoH, 2003), and this is a worldwide phenomenon.

Type
Chapter
Information
Cambridge Textbook of Effective Treatments in Psychiatry , pp. 402 - 412
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abernethy, D. R., Greenblatt, D. J. & Shader, R. I. (1981). Treatment of diazepam withdrawal syndrome with propranolol. Annals of Internal Medicine, 94, 354–5.CrossRefGoogle ScholarPubMed
APA Task Force (1990). Benzodiazepine dependence, toxicity and abuse: a Task Force Report of the American Psychiatric Association. Washington DC: APA.
Ashton, C. H. (1984). Benzodiazepine withdrawal: unfinished story. British Medical Journal, 288, 1135–40.CrossRefGoogle ScholarPubMed
Ashton, C. H. (1987). Benzodiazepine withdrawal: outcome in 50 patients. British Journal of Addiction, 82, 665–671.CrossRefGoogle ScholarPubMed
Ashton, C. H. (1995).Toxicity and adverse consequences of benzodiazepine use. Psychiatric Annales, 25, 158–65.CrossRefGoogle Scholar
Ashton, C. H. & Golding, J. F. (1989). Tranquillisers: prevalence, predictions and possible consequences, data from a large United Kingdom survey. British Journal of Addiction, 84, 541–6.CrossRefGoogle Scholar
Ashton, C., Rawlins, M. & Tyrer, S. (1990). A double blind placebo-controlled study of buspirone in diazepam withdrawal in chronic benzodiazepine users. British Journal of Psychiatry, 157, 232–8.CrossRefGoogle ScholarPubMed
Baillargeon, L., Landreville, P., Verreault, R., Beauchemin, J. P., Gregoire, J. P. & Morin, C. M. (2003). Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. Canadian Medical Association Journal, 169, 1015–20.Google ScholarPubMed
Balter, M. B., Manheimer, D. I., Mellinger, G. D. & Uhlenhuth, E. H. (1984). A cross national comparison of antianxiety/sedative use. Current Medical Research Opinion, 8, 5–20.Google Scholar
Bashir, K., King, M. & Ashworth, M. (1994). Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. British Journal of General Practice, 44, 408–12.Google ScholarPubMed
Best, D., Noble, A., Man, L., Gossop, M., Finch, E. & Strang, J. (2002). Factors surrounding long-term benzodiazepine prescribing in methadone maintenance clients. Journal of Substance Abuse Treatment, 7, 175–9.Google Scholar
Boyce, P. (2003). Commentary on, Gradual reduction of benzodiazepines, with or without cognitive behavioural therapy, increases successful withdrawal rates compared with no support in long-term users. Evidence Based Mental Health, 6(4), 119.CrossRefGoogle ScholarPubMed
Bruun, T. G. (1993). Abuse potential during use and withdrawal psychosis after treatment with the hypnotic zolpidem (Stilnoct). Ugeskr Laeger, 155(51), 4194–5.Google Scholar
Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M. & Sykora, K. (1986a). Withdrawal reaction after long-term therapeutic use of benzodiazepines. New England Journal of Medicine, 315, 854–9.CrossRefGoogle Scholar
Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H. D., Sanchez-Craig, M. & Simpkins, J. (1986b). Patterns of benzodiazepine abuse and dependence. British Journal of Addiction, 81, 87–94.CrossRefGoogle Scholar
Cantopher, T., Olivieri, S., Cleave, N. & Edwards, G. (1990). Chronic benzodiazepine dependence: a comparative study of abrupt withdrawal under propranolol cover versus gradual withdrawal. British Journal of Psychiatry, 156, 406–11.CrossRefGoogle ScholarPubMed
Cole, J. O. & Chiarello, R. J. (1990). The benzodiazepines as drugs of abuse. Journal of Psychiatric Research, 24, 135–44.CrossRefGoogle ScholarPubMed
Committee on Safety of Medicines (CSM) (1988). Benzodiazepines, dependence and withdrawal symptoms. Current Problems, 21, 1–2.
Coppell, H. D., Sellers, E. M. & Busto, U. (1986). Benzodiazepines as drugs of abuse and dependence. Recent Advances in Alcohol and Drug Problems, ed. Coppell, H. D., Glaser, F. H., Israel, Y.et al., vol. 9, p. 63. New York: Plenum Press.CrossRefGoogle Scholar
Cormack, M. A., Sweeney, K. G., Hughes-Jones, H. & Foot, G. A. (1994). Evaluation of an easy, cost-effective strategy for cutting benzodiazepine use in general practice. British Journal of Genearl Practice, 44(378), 5–8.Google ScholarPubMed
Couvée, J., Oude-Voshaar, R., van Balkom, A., & Zitman, F. (2003). Strategies to discontinue long term benzodiazepine use: a systematic review. In Towards a Treatment of Chronic Benzodiazepine Users Suffering from Depression, ed. Couvée, J.. The Netherlands: Glaxo SmithKline BV.
Curran, H. V., Collins, R., Fletcher, S., Kee, S. C., Woods, B. & Iliffe, S. (2003). Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychological Medicine, 33, 1223–37.CrossRefGoogle ScholarPubMed
Department of Health (DoH 2003). Prescription costs analysis (PCA 2003 online). Available: www.publications.doh.gov.uk/stats/pca2003.pdf.
Department of Health, Scottish Office Department of Health, Welsh Office, Department of Health and Social Services, Northern Ireland (1999). Drug Misuse and Dependence – Guidelines on Clinical Management.
Drug and Therapeutic Bulletin (DTB) (2004). What's wrong with prescribing hypnotics? 42(12), 89–93.CrossRef
Dundar, Y., Boland, A., Strobl, J.et al. (2004). Newer hypnotic drugs for the short term management of insomnia: a systematic review and economic evaluation. Health Technology Assessment, 8(24), iii–x, 1–125.CrossRefGoogle ScholarPubMed
DuPont, R. L. & Saylor, K. E. (1991). Sedatives/hypnotics and benzodiazepines. In Clinical Textbook of Addictive Disorders, ed. Frances, R. J. & Miller, S. I., pp. 69–102. New York & London: Guilford Press.Google Scholar
Eickelberg, S. J. & Mayo-Smith, M. F. (1998). Management of sedative-hypnotic intoxication and withdrawal. In Principles of Addiction Medicine, ed. Graham, A. W. & Schultz, T. K., pp. 441–55. ASAM Press.Google Scholar
Elsesser, K., Sartory, G. & Maurer, J. (1996). The efficacy of complaints management training in facilitating benzodiazepine withdrawal. Behaviour Research and Therapy, 34, 149–56.CrossRefGoogle ScholarPubMed
Fountain, J., Griffiths, P., Farrell, M., Gossop, M. & Strang, J. (1999). Benzodiazepines in polydrug-using repertoires: the impact of the decreased availability of temazepam gel-filled capsules. Drugs: Education, Prevention and Policy, 6(1), 61–9.Google Scholar
Ghodse, A. H. (1995). Drugs and Addictive Behaviour: A Guide to Treatment, 2nd edn, pp. 268–75. Oxford: Blackwell Science.Google Scholar
Gossop, M. (2003). Detoxification from benzodiazepines and sedatives. In Drug Addiction and its Treatment, pp. 127–9. Oxford, UK: Oxford University Press.Google ScholarPubMed
Gossop, M., Johns, A. & Green, L. (1986). Opiate withdrawal: inpatient versus outpatient programmes and preferred versus random assignment to treatment. British Medical Journal, 293, 103–4.CrossRefGoogle ScholarPubMed
Gossop, M., Marsden, J., Stewart, D. & Kidd, T. (2003). The National Treatment Outcome Research Study (NTORS): 4–5 year follow-up results. Addiction, 98(3), 291–303.CrossRefGoogle ScholarPubMed
Greenwood, J. (1996). Six years experience of sharing the care of Edinburgh's drug users. Psychiatric Bulletin, 20, 8–11.CrossRefGoogle Scholar
Hajak, G., Muller, W. E., Wittchen, H. U., Pittrow, D. & Kirch, W. (2003). Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction, 98, 1371–8.CrossRefGoogle ScholarPubMed
Hall, R. C. W. & Joffe, J. R. (1972). Aberrant response to diazepam: a new syndrome. American Journal of Psychiatry, 129, 738–42.CrossRefGoogle ScholarPubMed
Hallstrom, C. & Lader, M. (1981). Benzodiazepine withdrawal phenomena. International Pharmacopsychiatry, 16, 235–44.CrossRefGoogle ScholarPubMed
Harrison, M., Busto, U., Naranjo, C. A., Kaplan, H. L. & Sellers, E. M. (1984). Diazepam tapering in detoxification for high-dose benzodiazepine abuse. Clinical Pharmacology and Therapeutics, 36, 527–33.CrossRefGoogle ScholarPubMed
Heather, N., Bowie, A., Ashton, H.et al. (2004). Randomised controlled trial of two brief interventions against long-term benzodiazepine use: outcome of intervention. Addiction Research Theory, 12, 141–54.CrossRefGoogle Scholar
Higgitt, A., Golombok, S., Fonagy, P. & Lader, M. (1987). Group treatment of benzodiazepine dependence. British Journal of Addiction, 82, 517–32.CrossRefGoogle ScholarPubMed
Holton, A. & Tyrer, P. (1990). Five year outcome of patients withdrawn from long-term treatment with diazepam. British Medical Journal, 300, 1241–2.CrossRefGoogle ScholarPubMed
Isbell, H. & White, W. M. (1953). Clinical characteristics of addictions. American Journal of Medicine, 14, 558–65.CrossRefGoogle ScholarPubMed
Joint Formulary Committee (2004). British National Formulary. Edition 48. London: Royal Pharmaceutical Society of Great Britain and British Medical Association. Sept. 2004
Jones, I. R. & Sullivan, G. (1998). Physical dependence on zopiclone: case reports. British Medical Journal, 316, 117.CrossRefGoogle ScholarPubMed
Klein, E., Uhde, T. W. & Post, R. M. (1986). Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal. American Journal of Psychiatry, 143, 336–8.Google ScholarPubMed
Lader, M. H. (1999). Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?European Neuropsychopharmacology, 9 (Suppl. 6), S399–405.CrossRefGoogle ScholarPubMed
Lader, M. H. (1991). Avoiding long-term use of benzodiazepine drugs. Prescriber. March, pp. 79–83.Google Scholar
Lader, M. H. & Higgitt, A. C. (1986). Management of benzodiazepine dependence – Update 1986. British Journal of Addiction, 81, 7–9.CrossRefGoogle ScholarPubMed
Liappas, I. A., Malitas, P. N., Dimopoulos, N. P.et al. (2003). Zolpidem dependence case series; possible neurobiological mechanisms and clinical management. Journal of Psychopharmacology, 17, 131–5.CrossRefGoogle ScholarPubMed
Lingford-Hughes, A. R., Welch, S. & Nutt, D. J. (BAP Guidelines) (2004). Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 18(3), 305–7.CrossRefGoogle ScholarPubMed
Mackinnon, G. L. & Parker, W. A. (1982). Benzodiazepine withdrawal syndrome: a literature review and evaluation. American Journal of Drug and Alcohol Abuse, 9, 19–33.CrossRefGoogle ScholarPubMed
Martinez-Cano, H., Vela-Bueno, A., Iceta, M., Pomalima, R., Martinez-Gras, I. & Sobrino, M. P.(1996). Benzodiazepine types in high versus therapeutic dose dependence. Addiction, 91, 1179–86.CrossRefGoogle ScholarPubMed
Murphy, S. & Tyrer, P. (1991). A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence. British Journal of Psychiatry, 158, 511–16.CrossRefGoogle ScholarPubMed
Nathan, R. G., Robinson, D., Cherek, D. R., Sebastian, C. S., Hack, M. & Davison, S. (1986). Alternative treatments for withdrawing the long-term benzodiazepine user: a pilot study. International Journal of Addictions, 21(2), 195–211.CrossRefGoogle ScholarPubMed
National Institute for Clinical Excellence (NICE) (2004). Guidance on the use of zaleplon, zolpidem and zopiclone for short term management of insomnia. London: NICE (Technology Appraisal 77).
Noyes, R., Garvey, M. J., Cook, B. L. & Perry, D. J. (1988). Benzodiazepine withdrawal: a review of the evidence. Journal of Clinical Psychiatry, 49, 382–9.Google Scholar
Olajide, D. & Lader, M. H. (1987). A comparitive study of the efficacy of buspirone in relieving benzodiazepine withdrawal symptoms. Journal of Clinical Psychopharmacology, 7, 11–15.Google Scholar
Otto, M. W., Pollack, M. H., Sachs, G. S., Reiter, S. R., Meltzer-Brody, S. & Rosenbaum, J. F. (1993). Discontinuation of benzodiazepine treatment: efficacy of cognitive behavioural therapy for patients with panic disorder. American Journal of Psychiatry, 150, 1485–90.Google ScholarPubMed
Oude-Voshaar, R. C., Gorgels, W. J. & Mol, A. J. J. (2001). Behandelmethoden om langdurig benzodiazepinegebruik te staken [Treatment methods for discontinuation of long-term benzodiazepine use]. Nederlands Tijdschrift voor Geneeskunde, 145, 1347–50.Google Scholar
Oude-Voshaar, R. C., Gorgels, W. J. & Mol, A. J. J. (2003). Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial. British Journal of Psychiatry, 182, 498–504.CrossRefGoogle Scholar
Oude-Voshaar, R. C., Couvée, J. E., Balkom, A. J. L. M., Mulder, P. G. H. & Zitman, F. G. (2006a). Strategies for discontinuing long-term benzodiazepine use: meta-analysis. British Journal of Psychiatry, 189, 213–20.CrossRefGoogle Scholar
Oude-Voshaar, R. C., Gorgels, W. J., Mol, A. J.et al. (2006b). Long-term outcome of two forms of randomised benzodiazepine discontinuation. British Journal of Psychiatry, 188, 188–9.CrossRefGoogle Scholar
Perry, P. J., Stambaugh, R. L., Tsuang, M. T. & Smith, R. E., (1981). Sedative-hypnotic tolerance testing and withdrawal comparing diazepam to barbiturates. Journal of Clinical Psychopharmacology, 1(5), 289–96.CrossRefGoogle ScholarPubMed
Petrovic, M., Pevernagie, D., Noortgate, N.Mariman, A., Michielsen, W. & Afschrift, M. (1999). A programme for short-term withdrawal from benzodiazepines in geriatric hospital inpatients: Success rate and effect on subjective sleep quality. International Journal of Geriatric Psychiatry, 14(9), 754–60.3.0.CO;2-E>CrossRefGoogle ScholarPubMed
Petursson, H. & Lader, M. (1981). Benzodiazepine dependence. British Journal of Addiction, 76, 133–45.CrossRefGoogle ScholarPubMed
Poyares, D. R., Guilleminault, C., Ohayon, M. M. & Tufik, S. (2002). Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal?. Progress in Neuropsychopharmacology and Biological Psychiatry, 26(3), 539–45.CrossRefGoogle ScholarPubMed
Priest, R. G. & Montgomery, S. A. (1988). Benzodiazepines and dependence: a College statement. Bulletin Royal College of Psychiatrists, 12, 107–8.Google Scholar
Rasmussen, P. (1997). A role for phytotherapy in the treatment of benzodiazepine and opiate drug withdrawal. European Journal of Herbal Medicines 3(1), 11–21.Google Scholar
Rhodes, P. J., Rhodes, R. S. & McCurdy, J. H. (1984). Elimination kinetics and symptomatology of diazepam withdrawal in abusers. Clinical Toxicology, 22, 371–4.Google ScholarPubMed
Rickels, K., Case, W. G., Schweizer, E. E., Swenson, C. & Fridman, R. (1986). Low dose dependence in chronic benzodiazepine users: a preliminary report on 119 patients. Psychopharmacological Bulletin, 22, 407–15.Google ScholarPubMed
Rickels, K., Case, W. G., Schweizer, E., Garcia-Espana, F. & Fridman, R. (1989). Benzodiazepine dependence: management of discontinuation. Psychopharmacology Bulletin, 26, 63–8.Google Scholar
Rickels, K., DeMartinis, N., Rynn, M. & Mandos, L. (1999). Pharmacologic strategies for discontinuing benzodiazepine treatment. Journal of Clinical Psychopharmacology, 19(6) Suppl. 2, 12S–16S.CrossRefGoogle ScholarPubMed
Rickels, K., Schweizer, E., Case, W. G. & Greenblatt, D. J. (1990). Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. Archives of General Psychiatry, 47, 899–907.CrossRefGoogle ScholarPubMed
Rickels, K., DeMartinis, N., García-España, F., Greenblatt, D. J., Mandos, L. A. & Rynn, M. (2000). Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy. American Journal of Psychiatry, 157, 1973–9.CrossRefGoogle ScholarPubMed
Ries, R. K., Roy-Byrne, P. P., Ward, N. G., Neppe, V. & Cullison, S. (1989). Carbamazepine treatment for benzodiazepine withdrawal. American Journal of Psychiatry, 146, 536–7.Google ScholarPubMed
Robinson, G. M., Sellers, E. M. & Janacek, E. (1981). Barbiturate and hypnosedative withdrawal by a multiple oral Phenobarbital loading dose technique. Clinical and Pharmacological Therapy, 30(1), 71–6.CrossRefGoogle ScholarPubMed
Romach, M., Busto, U., Somer, G., Kaplan, H. I. & Sellers, E. (1995). Clinical aspects of chronic use of alprazolam and lorazepam. American Journal of Psychiatry, 152, 1161–7.Google ScholarPubMed
Ross, J. & Darke, S. (2000). The nature of benzodiazepine dependence among heroin users in Sydney, Australia. Addiction, 95, 1785–93.CrossRefGoogle ScholarPubMed
Sanchez-Craig, M., Cappell, H., Busto, U. & Kay, G. (1987). Cognitive-behavioural treatment for benzodiazepine dependence: a comparison of gradual versus abrupt cessation of drug intake. British Journal of Addiction, 82, 1317–27.CrossRefGoogle ScholarPubMed
Schweizer, E. & Rickels, K. (1986). Failure of buspirone to manage benzodiazepine withdrawal. American Journal of Psychiatry, 143, 1590–2.Google ScholarPubMed
Schweizer, E. & Rickels, K. (1998). Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatrica Scandinavica, 98 (Suppl. 393), 95–101.CrossRefGoogle Scholar
Schweizer, E., Rickels, K., Case, W. G. & Greenblatt, D. J. (1991). Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and outcome. Archives of General Psychiatry, 48, 448–52.CrossRefGoogle ScholarPubMed
Sees, K. L. (1991). Pharmacological adjuncts for the treatment of withdrawal syndromes. Journal of Psychoactive Drugs, 23, 179–93.CrossRefGoogle ScholarPubMed
Seivewright, N. & Dougal, W. (1993). Withdrawal symptoms from high dose benzodiazepines in polydrug users. Drug & Alcohol Dependence, 32, 15–23.CrossRefGoogle Scholar
Seivewright, H., Tyrer, P., Casey, P. & Seivewright, N. (1991). A three-year follow-up of psychiatric morbidity in urban and rural primary care. Psychological Medicine, 21, 495–503.CrossRefGoogle Scholar
Smith, D. E. & Wesson, D. R. (1970). A new method for treatment of barbiturate dependence. Journal of the American Medical Association, 23, 294–5.CrossRefGoogle Scholar
Smith, D. E. & Wesson, D. R. (1971). A phenobarbital technique for the withdrawal of barbiturate abuse. Archives of General Psychiatry, 24, 56–60.CrossRefGoogle Scholar
Smith, D. E. & Wesson, D. R. (1985). Benzodiazepine dependence syndromes. In The Benzodiazepines: Current Standards for Medical Practice, ed. Smith, D. E. & Wesson, D. R., pp. 235–48. Lancaster, UK: MTP Press.CrossRefGoogle Scholar
Smith, D. E., Landry, M. J. & Wesson, D. R. (1989). Barbiturate, sedative, hypnotic agents. In APA Task Force on Treatment of Psychiatric Disorders, pp. 1294–308. Washington DC: APA.Google Scholar
Spiegel, D. A., Bruce, T. J., Gregg, S. F. & Nuzzarello, A. (1994). Does cognitive behaviour therapy assist slow-taper alprazolam discontinuation in panic disorder?American Journal of Psychiatry, 151, 876–81.Google ScholarPubMed
Strang, J., Seivewright, N. & Farrell, M. (1992). Intravenous and other novel abuses of benzodiazepines; the opening of Pandora's box?. British Journal of Addiction, 87(10), 1373–5.CrossRefGoogle ScholarPubMed
Strang, J., Griffiths, P., Abbey, J. & Gossop, M. (1994). Survey of use of injected benzodiazepines among drug users in Britain. British Medical Journal, 308, 1082.CrossRefGoogle ScholarPubMed
Taylor, D. (1987). Current usage of benzodiazepines in Britain. In Current Clinical Practice, ed. Freeman, H. & Rue, Y., pp. 13–18. London: Royal Society of Medicine.Google Scholar
Taylor, S., McCracken, C. F., Wilson, K. C. & Copeland, J. R. (1998). Extent and appropriateness of benzodiazepine use. Results from an elderly urban community. British Journal of Psychiatry, 173, 433–8.CrossRefGoogle ScholarPubMed
Trickett, S. (1986). Coming off Tranquillisers and Sleeping Pills. Wellingborough, Northamptonshire: Thorsons Publishing Group.Google Scholar
Tyrer, P. (1980). Dependence on benzodiazepines. British Journal of Psychiatry, 137, 576–7.CrossRefGoogle ScholarPubMed
Tyrer, P. (1985). Clinical management of benzodiazepine dependence. British Medical Journal, 291, 1507.CrossRefGoogle ScholarPubMed
Tyrer, P. (1986). How to Stop Taking Tranquillisers. London: Sheldon Press.Google Scholar
Tyrer, P., Rutherford, D. & Huggett, T. (1981). Benzodiazepine withdrawal symptoms and propranolol. Lancet, i, 520–2.CrossRefGoogle Scholar
Tyrer, P., Owen, R. & Dawling, S. (1983). Gradual withdrawal of diazepam after long-term therapy. Lancet, 1, 1402–6.CrossRefGoogle ScholarPubMed
Tyrer, P., Murphy, S., Oates, G. & Kingdon, D. (1985). Psychological treatment for benzodiazepine dependence. Lancet, 1, 1042–3.CrossRefGoogle ScholarPubMed
Tyrer, P., Murphy, S. & Riley, P. (1990). The benzodiazepine withdrawal symptom questionnaire. Journal of Affective Disorders, 19, 53–61.CrossRefGoogle ScholarPubMed
Tyrer, P., Ferguson, B., Hallstrom, C.et al. (1996). A controlled trial of dothiepin and placebo in treating benzodiazepine withdrawal symptoms. British Journal of Psychiatry, 168, 457–61.CrossRefGoogle ScholarPubMed
Vartzopoulos, D., Bozikas, V., Phocas, C., Karavatos, A. & Kaprinis, G. (2000). Dependence on zolpidem in high dose. International Clinical Psychopharmacology, 15, 181–2.CrossRefGoogle ScholarPubMed
Vorma, H., Naukkarinen, H., Sarna, S. & Kuoppasalmi, K. (2002). Treatment of outpatients with complicated benzodiazepine dependence: comparison of two approaches. Addiction, 97, 851–9.CrossRefGoogle Scholar
Weizman, T., Gelkopf, M., Melamed, Y., Adelson, M. & Bleich, A. (2003). Treatment of benzodiazepine dependence in methadone maintenance treatment patients: a comparison of two therapeutic modalities and the role of psychiatric comorbidity. Australian and New Zealand Journal of Psychiatry, 37, 458–63.CrossRefGoogle ScholarPubMed
Wicks, W., Darke, S. & Ross, J. (2000). Clobazam maintenance among methadone maintenance patients with problematic benzodiazepine use; five case studies. Drug and Alcohol Reviews, 19, 401–5.CrossRefGoogle Scholar
Williams, H., Oyefeso, A. & Ghodse, A. (1996). Benzodiazepine misuse and dependence among opiate addiction treatment. Irish Journal of Psychological Medicine, 13, 62–4.CrossRefGoogle Scholar
Woods, J. H., Katz, J. L. & Winger, G. (1992). Benzodiazepines: use, abuse and consequences. Pharmacological Reviews, 44, 151–338.Google ScholarPubMed
Woody, G. E., O'Brien, C. P. & Greestein, R. (1975). Misuse and abuse of diazepam: an increasingly common medical problem. International Journal of Addiction, 10, 843–8.CrossRefGoogle Scholar
Zitman, F. G. & Couvée, J. E. (2001). Chronic benzodiazepine use in general practice patients with depression: an evaluation of controlled treatment and taper-off. Report on behalf of the Dutch Chronic Benzodiazepine Working Group. British Journal of Psychiatry, 178, 317–24.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Treatment of sedative-hypnotic dependence
    • By Karim Dar, Gatehouse Alcohol Clinic St. Bernard's Hospital Southall Middx UK, Manoj Kumar, Gatehouse Alcohol Clinic St. Bernard's Hospital Southall Middx UK
  • Edited by Peter Tyrer, Imperial College of Science, Technology and Medicine, London, Kenneth R. Silk, University of Michigan, Ann Arbor
  • Book: Cambridge Textbook of Effective Treatments in Psychiatry
  • Online publication: 12 May 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544392.023
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Treatment of sedative-hypnotic dependence
    • By Karim Dar, Gatehouse Alcohol Clinic St. Bernard's Hospital Southall Middx UK, Manoj Kumar, Gatehouse Alcohol Clinic St. Bernard's Hospital Southall Middx UK
  • Edited by Peter Tyrer, Imperial College of Science, Technology and Medicine, London, Kenneth R. Silk, University of Michigan, Ann Arbor
  • Book: Cambridge Textbook of Effective Treatments in Psychiatry
  • Online publication: 12 May 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544392.023
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Treatment of sedative-hypnotic dependence
    • By Karim Dar, Gatehouse Alcohol Clinic St. Bernard's Hospital Southall Middx UK, Manoj Kumar, Gatehouse Alcohol Clinic St. Bernard's Hospital Southall Middx UK
  • Edited by Peter Tyrer, Imperial College of Science, Technology and Medicine, London, Kenneth R. Silk, University of Michigan, Ann Arbor
  • Book: Cambridge Textbook of Effective Treatments in Psychiatry
  • Online publication: 12 May 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544392.023
Available formats
×